Catalyst Wire Dossier Catalyst Wire Dossier

brexanolone (Zulresso)

brexanolone · Sage Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for brexanolone (Zulresso), covering 2025-10-14 to 2025-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder [Phase 1]

See pricing